Month: June 2021

Controversial New Alzheimer’s Drug is Costly

Aduhelm, the recently approved medicine to treat Alzheimer’s disease, could single-handedly account for 1% of all healthcare spending by next year. The Food and Drug Administration okayed the controversial drug on June 7 to treat Alzheimer’s disease, which affects in the… Read Full Article (External Site) Dr. David LowemannDr. David Lowemann, M.Sc, Ph.D., is a […]

Published on June 17, 2021

Hospitalized COVID Patients Have One Thing in Common: They Are Not Vaccinated

As the number of COVID-19 hospitalizations dramatically decline across America, health care experts note that patients who are admitted have one thing in common: they are not vaccinated. Nearly every patient admitted to a hospital nationwide has not received the COVID-19… Read Full Article (External Site) Dr. David LowemannDr. David Lowemann, M.Sc, Ph.D., is a […]

Published on June 17, 2021

Niacin Enhancement for Parkinson’s Disease: An Effectiveness Trial

We previously reported that individuals with Parkinson’s disease (PD) present with lower vitamin B3 levels compared to controls. It may be related to carbidopa interaction, defective tryptophan metabolism, and stresses of night sleep disorder. Vitamin B3 is the energy source for all cells by producing NAD+ and NADP+ in redox reactions of oxidative phosphorylation. Thus, […]

Published on June 17, 2021